The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Health IT

Emanuel, Khosla Push for Autonomous AI Physicians

Oncologist and bioethicist Ezekiel Emanuel and venture capitalist Vinod Khosla argue that the medical community should be willing to let AI systems make autonomous clinical decisions, rather than insisting a physician always has the final say. In a Sept. 8 article for The Atlantic, cited by Becker's Hospital Review, the pair contend that requiring a human backup on every AI decision may hold back care that could be faster, cheaper, and in some cases more accurate than what doctors deliver today.

The view directly challenges the reigning standard for clinical AI, which keeps a licensed clinician "in the loop" to review and approve algorithmic recommendations. Regulators, hospitals, and malpractice frameworks are all built around that assumption. Emanuel and Khosla say the industry should at least experiment with removing it.

The argument is a viewpoint, not a policy change. But coming from a prominent bioethicist and a major health-tech investor, it signals a growing push to test where autonomous AI can safely operate, and it will sharpen debates over liability, FDA oversight, and patient trust.

More in Health IT

Health IT

Epic Opens Its Platform Wider to AI and Outside Developers

Epic used its Open@Epic developer conference to open its platform wider to outside AI and apps while reminding developers that the resulting traffic runs on hospitals' infrastructure.

Why it matters: As the dominant EHR vendor, Epic's decision to open its platform shapes how and where clinical AI gets deployed across most U.S. hospitals.

Health IT

After AI Go-Live, Who Owns Monitoring? Often No One

Health systems scrutinize AI before go-live, but post-deployment monitoring responsibilities often remain undefined, leaving no clear owner when models drift.

Why it matters: Unmonitored AI models can quietly degrade in clinical settings, putting patient safety at risk when no one is accountable for watching performance after launch.